ENTITY
Transcenta

Transcenta (6628 HK)

17
Analysis
Health Care • China
Transcenta is a clinical-stage biopharmaceutical company with integrated capabilities in the discovery, research, development, manufacturing, and business development of biopharmaceuticals. The company develops therapeutic antibody molecules for oncology and selected non-oncology indications, including bone and kidney disorders, and also provides contract development and manufacturing organization (CDMO) services. Transcenta is headquartered in Suzhou, China, and was founded in 2010.
more
bullish•Full Truck Alliance
•04 Jul 2021 10:21

ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullish•Transcenta
•02 Jul 2021 11:43

Transcenta (åˆ›čƒœ) Pre-IPO: Buy the Experienced Team

Formerly Mabspace, we think Transcenta has an experienced team with with innovative product though the immediate addressable market is not huge.

Logo
670 Views
Share
x